In animal experiment studies, Chinese researchers have found that a metabolite of the antiviral drug Remdesivir called GS-441524 could help inhibit the severe acute respiratory syndrome coronavirus 2 ...
BOSTON--(BUSINESS WIRE)--Gilead Sciences, Inc. (NASDAQ: GILD) today announced data from clinical and preclinical studies exploring the use of GS-6207, an investigational, novel, first-in-class ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Gilead Sciences is conducting a Phase 2 ...
The combination of a chemotherapy doublet (gemcitabine plus capecitabine) with a biologic doublet (bevacizumab plus erlotinib) in patients with advanced pancreatic adenocarcinoma: The TARGET study.
Change Does Not Affect Ongoing “All Oral” Clinical Trials Evaluating Multiple Direct-Acting Antivirals in Combination FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) today ...
Outcomes by CD30 expression in patients with CTCL receiving brentuximab vedotin (BV) vs physician's choice (PC) in the Phase 3 ALCANZA study. Response rates with pembrolizumab in combination with ...
The 2014 outbreak of Ebola virus, which caused more than 11,000 deaths in West Africa, has been brought to heel, but the need for effective Ebola treatments remains urgent. The drugmaker Gilead ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results